Literature DB >> 1534018

Using decision analysis to calculate the optimum treatment for microinvasive cervical cancer.

N Johnson1, R J Lilford, S E Jones, L McKenzie, P Billingsley, F F Songane.   

Abstract

Decision theory was used to calculate the optimum treatment of microscopic squamous cervical cancer using probabilities obtained from an exhaustive literature review and a range of plausible value estimates. This showed that if there is no vascular involvement, survival is maximised by conservative treatment if tumour invasion is less than 3 mm while treatment by radical surgery results in maximal survival rates if the tumour invasion is over 3 mm. Radical surgery also maximises survival for smaller lesions where lymph channel involvement is present, especially if a surgical mortality at the lower end of the reported range is assumed. Refinement of our analysis to include an assessment of patient values showed that these conclusions are still valid regardless of the patient's relative preference for death from surgery or death from cancer. However, the wish to preserve fertility sharply reduces the overall net benefit of surgery. Conservative treatment becomes the preferred option for all microinvasive lesions even for patients who are prepared to trade-off a small (e.g. 2%) risk of death in order to retain their fertility.

Entities:  

Mesh:

Year:  1992        PMID: 1534018      PMCID: PMC1977396          DOI: 10.1038/bjc.1992.151

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  37 in total

1.  Lymph node metastasis in microinvasive epidermoid cancer of the cervix.

Authors:  J W Bohm; P J Krupp; F Y Lee; H W Batson
Journal:  Obstet Gynecol       Date:  1976-07       Impact factor: 7.661

2.  Prognosis of uterine cervical cancer with extensive lymph node metastases. Special emphasis on the value of pelvic lymphadenectomy in the surgical treatment of uterine cervical cancer.

Authors:  C T Hsu; Y S Cheng; S C Su
Journal:  Am J Obstet Gynecol       Date:  1972-12-01       Impact factor: 8.661

3.  Microinvasive carcinoma of the uterine cervix.

Authors:  A B Ng; J W Reagan
Journal:  Am J Clin Pathol       Date:  1969-11       Impact factor: 2.493

4.  Borderline microinvasive carcinoma of the cervix.

Authors:  E J Wilkinson; R A Komorowski
Journal:  Obstet Gynecol       Date:  1978-04       Impact factor: 7.661

5.  Diagnosis and management of stage 1A (microinvasive) carcinoma of the cervix.

Authors:  J G Boutselis; J C Ullery; L Charme
Journal:  Am J Obstet Gynecol       Date:  1971-08-01       Impact factor: 8.661

6.  Microinvasive carcinoma of the cervix.

Authors:  M H Leman; W L Benson; R J Kurman; R C Park
Journal:  Obstet Gynecol       Date:  1976-11       Impact factor: 7.661

7.  Microinvasive carcinoma of the cervix.

Authors:  R M Ruch; J A Pitcock; W A Ruch
Journal:  Am J Obstet Gynecol       Date:  1976-05-01       Impact factor: 8.661

8.  Diagnosis and management of microinvasive (stage IA) carcinoma of the uterine cervix.

Authors:  H E Averette; J H Nelson; A B Ng; W J Hoskins; J G Boyce; J H Ford
Journal:  Cancer       Date:  1976-07       Impact factor: 6.860

9.  Management of stage IA carcinoma of the cervix.

Authors:  W T Creasman; B F Fetter; D L Clarke-Pearson; L Kaufmann; R T Parker
Journal:  Am J Obstet Gynecol       Date:  1985-09-15       Impact factor: 8.661

10.  Results of treatment of early stage I carcinoma of the uterine cervix with intracavitary radium alone.

Authors:  A D Hamberger; G H Fletcher; J T Wharton
Journal:  Cancer       Date:  1978-03       Impact factor: 6.860

View more
  3 in total

Review 1.  Decision analysis in medicine.

Authors:  J G Thornton; R J Lilford; N Johnson
Journal:  BMJ       Date:  1992-04-25

Review 2.  Decision analysis and the implementation of research findings.

Authors:  R J Lilford; S G Pauker; D A Braunholtz; J Chard
Journal:  BMJ       Date:  1998-08-08

3.  The clinical decision analysis using decision tree.

Authors:  Jong-Myon Bae
Journal:  Epidemiol Health       Date:  2014-10-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.